Lyra Therapeutics Files 8-K
Ticker: LYRA · Form: 8-K · Filed: Jun 9, 2025 · CIK: 1327273
| Field | Detail |
|---|---|
| Company | Lyra Therapeutics, INC. (LYRA) |
| Form Type | 8-K |
| Filed Date | Jun 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-filing, financials
TL;DR
Lyra Therapeutics filed an 8-K on 6/9/25. Nothing major, just standard reporting.
AI Summary
Lyra Therapeutics, Inc. filed an 8-K on June 9, 2025, reporting other events and financial statements. The company, formerly known as Arsenal Medical, Inc., is incorporated in Delaware and headquartered in Watertown, MA.
Why It Matters
This filing provides an update on Lyra Therapeutics' corporate activities and financial reporting, which is important for investors to monitor the company's status.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for other events and financial statements, with no immediate indication of significant negative developments.
Key Players & Entities
- Lyra Therapeutics, Inc. (company) — Registrant
- June 9, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Watertown, Massachusetts (location) — Address of Principal Executive Offices
- Arsenal Medical, Inc. (company) — Former Company Name
FAQ
What is the primary purpose of this 8-K filing for Lyra Therapeutics, Inc.?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of June 9, 2025.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on June 9, 2025.
In which state is Lyra Therapeutics, Inc. incorporated?
Lyra Therapeutics, Inc. is incorporated in Delaware.
What is the principal executive office address for Lyra Therapeutics, Inc.?
The principal executive office address for Lyra Therapeutics, Inc. is 480 Arsenal Way, Watertown, Massachusetts 02472.
Has Lyra Therapeutics, Inc. operated under any former company names?
Yes, Lyra Therapeutics, Inc. has operated under former company names including Arsenal Medical, Inc., Arsenal Vascular, Inc., and 480 Biomedical, Inc.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 9, 2025 regarding Lyra Therapeutics, Inc. (LYRA).